Wave Life Sciences Ltd. (WVE) has a consensus analyst rating of Buy, based on 25 analysts covering the stock. Of those, 24 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for WVE is $32.50, representing a +339.8% upside from the current price of $7.39. Price targets range from a low of $26.00 to a high of $50.00.
